The use of tobacco and/or alcohol is linked with the occurrence of head and neck squamous cell carcinoma, esophagus cancer and lung cancer. If these carcinogenic factors can induce the development of a cancer in one of these locations, it would seem reasonable that a second cancer could appear in another of those areas, at the same time or at some point in the future. Recent developments This is the reason why one can consider that triple endoscopy is required as the optimal evaluation in patients with head and neck cancer. Nevertheless, the usefulness of this systematic procedure, which includes nasopharyngoscopy, laryngoscopy, pharyngoscopy, bronchoscopy and esophagoscopy, is debatable. The low number of head and neck cancers associated with synchronous primary cancers in the esophagus and/or lungs reported by several studies does not support this procedure and its morbidity. In contrast, in other studies a higher rate was observed and the authors pointed out the impact of such findings on treatment strategy, suggesting the benefit of routine triple endoscopy. One can conclude that the relevance of routine triple endoscopy is related to the rate of second synchronous primary cancer detected. A search to identify predictive factors of synchronous cancer occurrence will therefore be required. Summary This review summarizes the available data in the literature and highlights the need for selected patients with head and neck cancer to receive triple endoscopy.
Introduction
The use of tobacco and/or alcohol is linked with the occurrence of head and neck squamous cell carcinoma, esophagus cancer and lung cancer. Because these carcinogenic factors are the same for the above locations, it is not surprising that, if a head and neck squamous cell carcinoma, an esophagus cancer or a lung cancer is diagnosed, a second cancer should appear in another of those areas at the same time or at some point in the future [1] . So, one can consider that triple endoscopy, which includes nasopharyngoscopy, laryngoscopy, pharyngoscopy, bronchoscopy and esophagoscopy, is the optimal evaluation [2,3]. If it seems evident that endoscopy is the best method for staging head and neck cancer, however, routine triple endoscopy is still debatable.
The conclusion may not be definitive and this review does not aim to close the debate. Nevertheless, reaching a conclusion requires several elements: the rate of synchronous second primary associated with head and neck squamous cell carcinoma, the efficacy of routine triple endoscopy, the availability of other diagnostic tests, the identification of factors related with higher or lower risk of occurrence of synchronous primary cancers, the impact of such a discovery on treatment strategy and the possible benefit in terms of survival. Relying on those points, we will try to establish a reasonable recommendation.
Rate of second synchronous primary cancer in patients with head and neck squamous cell carcinoma
Multiple upper aerodigestive tract cancer occurrence was first described in 1860 by Billroth and Von Winiwarter [4] . The field cancerization hypothesis suggests that because the upper aerodigestive tract has been entirely exposed to the two main exogenous carcinogenic factors, tobacco and alcohol, the development of multifocal cancers is not surprising [1] . In all cases, these tumors were considered to be second synchronous primaries based on their localization at a distant site. One has to keep in mind the fact that only cytogenetic comparison between the tumor localizations may show differences that could confirm the status of two distinct synchronous cancers and exclude locoregional metastasis.
The incidence of a metachronous primary lung cancer ranges between 2.7 and 3.2% with a 5-year median follow-up. The incidence of second esophagus cancer following the treatment of a primary head and neck carcinoma ranges between 0 and 3.2% over a 2-10 years median follow-up period [2, [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] . Nonetheless, all the authors concluded that a systematic search for a second primary tumor during surveillance is not recommended.
In the literature, the association of head and neck squamous cell carcinoma with synchronous primary cancers in the esophagus and/or lungs varies widely. The occurrence rates range between 1.3 and 18% [5, [16] [17] [18] [19] [20] [21] . The heterogeneous use of chest radiographs or thoracic computer tomography (CT) scan may explain this variability. In our recent study [22] , all 487 patients with head and neck cancer had a normal thoracic CT scan. The rate of second synchronous cancer detected by routine triple endoscopy was 2.9%. One can suggest that the variability of second primary cancer does not strongly support the systematic use of routine triple endoscopy.
Is routine triple endoscopy efficient? Are other diagnostic tests available?
The role of panendoscopy has been compared with other investigation methods such as new imaging techniques including the CT scan, magnetic resonance imaging or positron emission tomography [23] . Triple endoscopy was still considered as the most effective strategy to detect second primary tumors [24] [25] [26] .
The efficacy of esophagoscopy is still debated. Grossman [27] conducted a prospective study of 268 patients with head and neck cancer, all of whom underwent esophagoscopy. Synchronous esophageal primary tumors were found in 1.9% of the patients. Shiozaki et al. [28] found a rate of 5.1% for simultaneous esophageal lesions in 178 patients using endoscopy in conjunction with iodine staining. Benninger et al. [25] detected 1.5% asymptomatic esophagus cancers in two consecutive studies. In their series of 788 patients with head and neck cancer, Makuuchi et al. [29] detected esophageal cancer in 11.8% of the patients. Around three-quarters of these patients had an early superficial lesion, a candidate for local excision using endoscopic resection techniques. By contrast, Davidson et al. [21] found no synchronous esophagus carcinoma among 154 patients with head and neck cancer.
The role of bronchoscopy is questioned even more strongly. Several published studies have shown that it is not valuable. The rate of synchronous lung carcinoma ranged from 0.7 to 4.5% [3,21,24,28,30 •• ]. In our recent study, esophagus and tracheobronchial endoscopies detected 62 suspect lesions among 487 head and neck cancers. Of them, only 15 (2.9%) were second synchronous primary invasive carcinomas. Four and five lesions were in-situ carcinomas of the esophageal or the tracheobronchial tracts. Thirty lesions were moderate or severe dysplasias. The treatment of such lesions is still debatable but assuredly requires stringent follow-up. In total, triple endoscopy detected primary esophagus squamous cell carcinomas in 2% of patients and lung primary cancers in 1% of patients. Triple endoscopy can be considered as an effective test to detect second primary tumors (see Table 1 ).
Is the detection of second primary cancer relevant in terms of treatment strategy?
One can consider of paramount importance the detection of a synchronous second carcinoma. The occurrence of a second primary tumor, soon after the treatment of the head and neck cancer is 'both embarrassing and disheartening' according to the pertinent description made by Shaha et al. [24] : embarrassing because when a patient comes back with a nondiagnosed second primary tumor this event could be assimilated with ineffective medical care; disheartening because the early detection at presentation might have allowed appropriate curativeintent treatment for both tumors. Delayed diagnosis does not facilitate curative strategy for the second tumor with the possible superposition of radiotherapy fields and the interaction of surgical procedures. Moreover, a possible heavy therapy for the head and neck cancer may have been useless if the second primary extension does not allow a curative-intent treatment. In our study, the strategy regarding the treatment of the head and neck primary tumor was modified in all cases by the presence of a second esophageal and/or lung primary tumor. Curative-intent treatment was planned for both tumors among the 10 patients with second primary esophagus cancer. For six patients, concomitant chemoradiotherapy was planned to treat both cancers simultaneously. For four patients, induction chemotherapy was administered followed by radiotherapy including both head and neck and esophagus tumor areas. Curativeintent treatment was planned for both tumors among the five patients with second primary lung cancer except one with a metastasis at presentation. A patient with a triple primary cancer received concomitant chemoradiotherapy on the head and neck and esophagus cancer, followed by endobronchial radiotherapy of his bronchial tumor. One patient underwent total laryngectomy followed by combined chemoradiotherapy for the lung cancer. One patient had concomitant chemoradiotherapy for the primary lesion of the head and neck followed by endobronchial radiotherapy of the bronchial cancer. Surgery was performed on both sites in one case. Clearly, the early detection of a second primary cancer had a major impact on the treatment strategy and allowed a curative-intent strategy in most cases.
Does the detection of second primary cancer have a significant impact in terms of survival?
To identify this second neoplasm, routine triple endoscopy has been recommended by many authors [2,3]. There is still a diversity of opinion regarding the usefulness of searching for second primary cancers. It is considered that the development of second primary tumors is frequent enough to warrant further investigation, and routine triple endoscopy is essential for all patients with head and neck cancer. It is to be stressed that the clinical benefit of the early identification of an asymptomatic second tumor is still undetermined. No study has yet examined whether patients with synchronous pulmonary or esophageal tumors have increased survival if their tumors are detected with a routine endoscopy when they are asymptomatic, instead of later [31, 32] .
Is there an identified factor predicting the risk of occurrence of a second primary cancer?
The incidence of second esophagus cancer following the treatment of a primary head and neck carcinoma seems to be independent of the stage of the primary head and neck tumor, taking into account that patients with more advanced disease have shorter survival and a lower risk of developing metachronous cancers. In all cases, the major risk factor remains the continuous abuse of alcohol and tobacco after the initial head and neck tumor treatment.
Few physicians believe that a systematic search for a second cancer is required for an advanced primary head and neck tumor. This belief is unfounded and the theoretical hypothesis of field cancerization effect suggests no relationship between the occurrence of a second cancer and the stage of the first one. Nevertheless, as a result of this belief, the frequency of routine triple endoscopy varies widely. Deleyiannis et al. [33] , relying on data from the National Cancer Institute's Surveillance, Epidemiology, and End Results Program, have assessed the frequency to which esophagoscopy and bronchoscopy are being used in the United States to evaluate patients with head and neck cancer. Among patients with an early, local disease, the rates of esophagoscopy and bronchoscopy varied widely, depending on where the patient was treated. The rates of esophagoscopy and bronchoscopy ranged from 12.9 to 39.8% and from 6.9 to 32.6% of the patients, respectively. These rates increased from 22.2 to 59.7% for esophagoscopy and from 12.8 to 50.7% for bronchoscopy in patients with advanced regional cancers.
The relationship between the risk of second cancer and the anatomic site of the primary tumor remains controversial. In our study, esophagoscopy detected esophageal cancers in 2% of cases. Interestingly, this incidence is dramatically higher among patients with a hypopharynx tumor. A second esophagus cancer was found in 9.2% of patients in this subgroup. By contrast, no case of esophageal cancer was detected for patients with an oral cavity tumor. These findings suggest that if routine esophagoscopy is debatable owing to the low incidence of second primary esophageal cancer, a search for a second primary has to be recommended among patients with hypopharynx carcinoma.
Conclusion
Triple endoscopy is probably the best evaluation technique to search for second esophageal and/or lung primary tumors. The low overall incidence rate may suggest avoiding such a heavy procedure. In addition, the role of bronchoscopy in the presence of a normal thoracic CT scan could be questioned, considering the low rate of lung cancer detected. In total, one can consider that only esophagoscopy for patients with hypopharynx squamous cell carcinoma remains relevant. On the other hand, the impact of second primary cancer on the treatment of the head and neck cancer is major, even if its impact in terms of survival is not established. In all cases, the occurrence of a second primary tumor, soon after the treatment of the head and neck cancer, is 'both embarrassing and disheartening' according to the pertinent description made by Shaha, and will not allow optimal treatment.
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